These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 18648727

  • 1. Effects of ivabradine on allograft function and exercise performance in heart transplant recipients with permanent sinus tachycardia.
    Zhang R, Haverich A, Strüber M, Simon A, Pichlmaier M, Bara C.
    Clin Res Cardiol; 2008 Nov; 97(11):811-9. PubMed ID: 18648727
    [Abstract] [Full Text] [Related]

  • 2. Lasting reduction of heart transplant tachycardia with ivabradine is effective and well tolerated: results of 48-month study.
    Zhang R, Bobylev D, Stiefel P, Haverich A, Bara C.
    Clin Res Cardiol; 2012 Aug; 101(8):631-6. PubMed ID: 22391988
    [Abstract] [Full Text] [Related]

  • 3. Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart.
    Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, Doesch AO.
    Clin Res Cardiol; 2018 Feb; 107(2):138-147. PubMed ID: 29098378
    [Abstract] [Full Text] [Related]

  • 4. Inappropriate sinus tachycardia in a heart transplant successfully treated with ivabradine.
    Mehta N, Bapat A, Tedrow U, Stevenson WG, Koplan B.
    Europace; 2017 Jul 01; 19(7):1100. PubMed ID: 28431002
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments.
    Kaplinsky E, Comes FP, Urondo LS, Ayma FP.
    Cardiol J; 2010 Jul 01; 17(2):166-71. PubMed ID: 20544616
    [Abstract] [Full Text] [Related]

  • 6. Treatment of inappropriate sinus tachycardia with ivabradine.
    Rakovec P.
    Wien Klin Wochenschr; 2009 Jul 01; 121(21-22):715-8. PubMed ID: 19998013
    [Abstract] [Full Text] [Related]

  • 7. Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study.
    Doesch AO, Mueller S, Erbel C, Gleissner CA, Frankenstein L, Hardt S, Ruhparwar A, Ehlermann P, Dengler T, Katus HA.
    Drug Des Devel Ther; 2013 Jul 01; 7():1323-8. PubMed ID: 24235815
    [Abstract] [Full Text] [Related]

  • 8. Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipients.
    Doesch AO, Ammon K, Konstandin M, Celik S, Kristen A, Frankenstein L, Buss S, Hardt S, Sack FU, Katus HA, Dengler TJ.
    Transplantation; 2009 Sep 27; 88(6):835-41. PubMed ID: 19920784
    [Abstract] [Full Text] [Related]

  • 9. Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation.
    Rivinius R, Helmschrott M, Rahm AK, Darche FF, Thomas D, Bruckner T, Doesch AO, Katus HA, Ehlermann P.
    Clin Res Cardiol; 2022 Feb 27; 111(2):141-153. PubMed ID: 32572551
    [Abstract] [Full Text] [Related]

  • 10. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
    Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Wranicz JK.
    Europace; 2013 Jan 27; 15(1):116-21. PubMed ID: 22772053
    [Abstract] [Full Text] [Related]

  • 11. β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.
    Fischer-Rasokat U, Honold J, Lochmann D, Wolter S, Liebetrau C, Fichtlscherer S, Möllmann H, Spyridopoulos I, Hamm CW.
    Clin Res Cardiol; 2016 Jun 27; 105(6):527-34. PubMed ID: 26687495
    [Abstract] [Full Text] [Related]

  • 12. Successful use of ivabradine in a 10-year-old patient with graft failure after heart transplantation.
    Ogawa Y, Urata S, Inuzuka R.
    Cardiol Young; 2023 Apr 27; 33(4):649-651. PubMed ID: 35864814
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of ivabradine in a case of inappropriate sinus tachycardia and ventricular dysfunction.
    Sette A, Martino A, Lioy E, Calò L.
    J Cardiovasc Electrophysiol; 2010 Jul 27; 21(7):815-7. PubMed ID: 20233274
    [Abstract] [Full Text] [Related]

  • 14. Ivabradine in patients with inappropriate sinus tachycardia.
    Zellerhoff S, Hinterseer M, Felix Krull B, Schulze-Bahr E, Fabritz L, Breithardt G, Kirchhof P, Kääb S.
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec 27; 382(5-6):483-6. PubMed ID: 20859616
    [Abstract] [Full Text] [Related]

  • 15. Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successful radiofrequency catheter ablation of atrioventricular node slow pathway.
    Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Wranicz JK.
    Pacing Clin Electrophysiol; 2013 Jan 27; 36(1):42-9. PubMed ID: 23078130
    [Abstract] [Full Text] [Related]

  • 16. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2007 Oct 27; 84(8):988-96. PubMed ID: 17989604
    [Abstract] [Full Text] [Related]

  • 17. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia.
    Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Cygankiewicz I, Wranicz JK.
    J Cardiovasc Pharmacol Ther; 2013 Jul 27; 18(4):338-44. PubMed ID: 23426376
    [Abstract] [Full Text] [Related]

  • 18. The use of ivabradine for inappropriate sinus tachycardia.
    Weyn T, Stockman D, Degreef Y.
    Acta Cardiol; 2011 Apr 27; 66(2):259-62. PubMed ID: 21591589
    [Abstract] [Full Text] [Related]

  • 19. Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope.
    Sutton R, Salukhe TV, Franzen-McManus AC, Collins A, Lim PB, Francis DP.
    Europace; 2014 Feb 27; 16(2):284-8. PubMed ID: 24072450
    [Abstract] [Full Text] [Related]

  • 20. Effect of Ivabradine on Heart Rate and Duration of Exercise in Patients With Mild-to-Moderate Mitral Stenosis: A Randomized Comparison With Metoprolol.
    Saggu DK, Narain VS, Dwivedi SK, Sethi R, Chandra S, Puri A, Saran RK.
    J Cardiovasc Pharmacol; 2015 Jun 27; 65(6):552-4. PubMed ID: 25636072
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.